Source link : https://www.newshealth.biz/health-news/sglt2-inhibitors-associated-with-better-survival-in-pah/
BOSTON — The use of sodium-glucose cotransporter-2 (SGLT2) inhibitors is associated with reduced short- and long-term mortality among patients with pulmonary arterial hypertension (PAH), according to results from a new propensity score–matched analysis. “There are a lot of new studies that show benefits [of SGLT2 inhibitors] in heart failure, in [chronic kidney disease], and of […]
Author : News Health
Publish date : 2024-10-08 13:18:16
Copyright for syndicated content belongs to the linked Source.